Longsworth Todd Christopher's Form 4 filing
NovoCure Ltd (NVCR) · filed Mar 7, 2022
- Accession no.
- 0001645113-22-000023
- Filed
- Mar 7, 2022
- Trade date
- Mar 3-4, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $220.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Longsworth Todd ChristopherCIK 0001693530 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2022 | Ordinary Shares | SSaleDisposed | −1,094 | $74.50 | −$81,503 | 66,774 | Direct | |
| Mar 4, 2022 | Ordinary Shares | SSaleDisposed | −1,973 | $70.41 | −$138,918.93 | 64,801 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2022 | Ordinary Shares | AGrant or awardAcquired | +6,106 | $80.59 | +$492,082.54 | 6,106 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.